研究发现,Idorsia的睡眠药物在患有失眠和鼻腔不育的老年人中显示出积极的效果。 Idorsia's sleep drug shows positive results in older adults with insomnia and nocturia, study finds.

瑞士一家制药公司Idorsia在55岁以上患有慢性失眠和鼻腔疾病病人的睡眠药物 -- -- 干燥剂 -- -- 中公布了积极结果。 Idorsia, a Swiss pharmaceutical company, has published positive results for its sleep medication, daridorexant, in patients over 55 with chronic insomnia and nocturia. 《睡眠研究期刊》的研究表明,每天50毫克剂量的剂量改善了睡眠时间,减少了失眠和腹腔症状,没有产生严重的副作用。 The study in the Journal of Sleep Research shows that a 50 mg daily dose improved sleep time, reduced insomnia and nocturia symptoms, and had no serious side effects. 审判包括60名男女平分的参加者,结果显示睡眠和日间工作有显著改善。 The trial included 60 participants split equally by gender, with results showing significant improvements in sleep and daytime functioning.